Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MS consortium pilot

ABSTRACT: Gut dysbiosis in patients with multiple sclerosis

PROVIDER: PRJEB99111 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR2105380.fastq.gz	Fastqsanger.gz
	ERR2105390.fastq.gz	Fastqsanger.gz
	ERR2105400.fastq.gz	Fastqsanger.gz
	ERR2105410.fastq.gz	Fastqsanger.gz
	ERR2105420.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 147

Similar Datasets

human metagenome

Project description:Multiple Sclerosis associated gut dysbiosis marker

| PRJNA875026 | ENA

CSF CD4+ T cells in MS

Project description:Single-cell transcriptome profiling of disease-related lymphocytes in patients with multiple sclerosis

2021-04-14 | GSE172003 | GEO

Gene-expression in peripheral blood mononuclear cells from untreated MS patients

Project description:The aim of this study was to identify differentially expressed genes in peripheral blood mononuclear cells from MS patients that were responders or non-responders to the neuroantigen myelin basic protein. Using microarray we measured mRNA-expression levels in freshly isolated peripheral blood mononuclear cells from 17 untreated patients with multiple sclerosis. Based on studies, measuring the responses of blood derived T-cells to myelin basic protein ex vivo, these 17 untreated MS-patients can be divided into two groups: 4 of the untreated multiple sclerosis patients had T-cells that responded to myelin basic protein ex vivo whereas 13 untreated MS patients had T-cells that did not respond to myelin basic protein ex vivo.

2014-11-28 | E-MTAB-2707 | biostudies-arrayexpress

Project description:Gut microbiome in Multiple sclerosis patients

| PRJNA889427 | ENA

Project description:Gut metagenome of Multiple Sclerosis patients

| PRJNA1245671 | ENA

Epigenome analysis of CD4 T cells from treated and untreated patients with multiple sclerosis (MS)

Project description:Genome wide DNA methylation profiling of CD4 T cells from treated and untreated patients with multiple sclerosis. The Illumina InfiniumEPIC methylation Beadchip was used to obtain DNA methylation profiles across approximately 850,000 CpGs of CD4 T cells from patients with multiple sclerosis.

2018-04-03 | GSE112596 | GEO

Opioid-induced gut microbial disruption leads to gut barrier compromise and sustained systemic inflammation.

Project description:Morphine and its pharmacological derivatives are the most prescribed analgesics for moderate to severe pain management. However, chronic use of morphine reduces pathogen clearance and induces bacterial translocation across the gut barrier. The enteric microbiome has been shown to play a critical role in the preservation of the mucosal barrier function and metabolic homeostasis. Here, we show for the first time, using bacterial 16s rDNA sequencing, that chronic morphine treatment significantly alters the gut microbial composition and induces preferential expansion of the gram-positive pathogenic and reduction of bile-deconjugating bacterial strains. A significant reduction in both primary and secondary bile acid levels was seen in the gut, but not in the liver with morphine treatment. Morphine induced microbial dysbiosis and gut barrier disruption was rescued by transplanting placebo-treated microbiota into morphine-treated animals, indicating that microbiome modulation could be exploited as a therapeutic strategy for patients using morphine for pain management. In this study, we establish a link between the two phenomena, namely gut barrier compromise and dysregulated bile acid metabolism. We show for the first time that morphine fosters significant gut microbial dysbiosis and disrupts cholesterol/bile acid metabolism. Changes in the gut microbial composition is strongly correlated to disruption in host inflammatory homeostasis13,14 and in many diseases (e.g. cancer/HIV infection), persistent inflammation is known to aid and promote the progression of the primary morbidity. We show here that chronic morphine, gut microbial dysbiosis, disruption of cholesterol/bile acid metabolism and gut inflammation; have a linear correlation. This opens up the prospect of devising minimally invasive adjunct treatment strategies involving microbiome and bile acid modulation and thus bringing down morphine-mediated inflammation in the host.

2016-06-01 | E-MTAB-3722 | biostudies-arrayexpress

Project description:WTCCC1 project Multiple Sclerosis (MS) samples

| EGAD00000000012 | EGA

Project description:WTCCC2 project Multiple Sclerosis (MS) samples

| EGAD00000000120 | EGA

MS study 2020

Project description:Longitudinal changes of stool and oral microbiota composition in patients with multiple sclerosis undergoing B-cell depletion

| PRJEB44538 | ENA